Scientists hunt for autism genes in large blood study

NCT ID NCT07311213

Not yet recruiting Knowledge-focused Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to collect blood samples from 450 people, including individuals with autism spectrum disorder (ASD), their relatives, and healthy controls. Researchers will isolate cells from the blood to study genetic factors and biological processes linked to autism. The goal is to better understand what causes ASD and identify potential targets for future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help identify new genetic causes and biological pathways in autism, potentially pointing toward future therapeutic targets.
What could go wrong: This is an early-stage observational study, not a treatment trial. It may not directly lead to new therapies, and findings may take years to translate into clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial septal defect autism autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASD AUTISM DISORDER

Contacts and locations

Locations

Hôpital Robert Debré

Paris, 75019, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.